IL33 and neoplasm: Given that IL-33 is localized in both tumor and fibroblastic cells (unlike the healthy LN), and additionally that IL-33 content is increased in the tumor of patients with lymphatic metastases, it is suggested that IL-33 could participate in mechanisms of tumor progression, either in an autocrine or paracrine fashion.